| Evan M Berger, | |
|
3235 Academy Ave Ste 200, Portsmouth, VA 23703-3200 | |
| (757) 397-7858 | |
| Not Available |
| Full Name | Evan M Berger |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 10 Years |
| Location | 3235 Academy Ave Ste 200, Portsmouth, Virginia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1356769731 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207WX0107X | Ophthalmology - Retina Specialist | 0101270075 (Virginia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Sentara Norfolk General Hospital | Norfolk, VA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Retina And Vitreous Center Pc | 4486699717 | 5 |
| Retina And Vitreous Center Pc | 4486699717 | 5 |
News Archive
Low birth weight infants are host to numerous microorganisms immediately after birth, and the microbiomes of their mouths and gut start out very similar but differentiate significantly by day 15 according to a study published in mBio-, the online open-access journal of the American Society for Microbiology.
MedDay, a biotechnology company focused on the treatment of nervous system disorders, reports additional positive data from its pivotal Phase III clinical trial, MS-SPI, with MD1003, a highly-concentrated pharmaceutical grade biotin, in patients with Progressive Multiple Sclerosis.
Excessive activity of an immune system gene previously linked to schizophrenia reproduces neural and behavioral aspects of the disease in mice, according to a new study publishing on January 14 in the open-access journal PLOS Biology by Ashley Comer and Alberto Cruz-Martín of Boston University and colleagues.
A study published recently in the Journal of Neuroscience points, for the first time, to the gene trkC as a factor in susceptibility to the disease. The researchers define the specific mechanism for the formation of fear memories which will help in the development of new pharmacological and cognitive treatments.
Pioneering research using the tropical zebrafish could provide new insights into the genetic basis of myopathy, a type of human muscle disease.
› Verified 5 days ago
| Entity Name | Tidewater Eye Center Spc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1578638748 PECOS PAC ID: 7719938679 Enrollment ID: O20050208000963 |
News Archive
Low birth weight infants are host to numerous microorganisms immediately after birth, and the microbiomes of their mouths and gut start out very similar but differentiate significantly by day 15 according to a study published in mBio-, the online open-access journal of the American Society for Microbiology.
MedDay, a biotechnology company focused on the treatment of nervous system disorders, reports additional positive data from its pivotal Phase III clinical trial, MS-SPI, with MD1003, a highly-concentrated pharmaceutical grade biotin, in patients with Progressive Multiple Sclerosis.
Excessive activity of an immune system gene previously linked to schizophrenia reproduces neural and behavioral aspects of the disease in mice, according to a new study publishing on January 14 in the open-access journal PLOS Biology by Ashley Comer and Alberto Cruz-Martín of Boston University and colleagues.
A study published recently in the Journal of Neuroscience points, for the first time, to the gene trkC as a factor in susceptibility to the disease. The researchers define the specific mechanism for the formation of fear memories which will help in the development of new pharmacological and cognitive treatments.
Pioneering research using the tropical zebrafish could provide new insights into the genetic basis of myopathy, a type of human muscle disease.
› Verified 5 days ago
| Entity Name | Retina & Vitreous Center Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1639252000 PECOS PAC ID: 4486699717 Enrollment ID: O20050627000849 |
News Archive
Low birth weight infants are host to numerous microorganisms immediately after birth, and the microbiomes of their mouths and gut start out very similar but differentiate significantly by day 15 according to a study published in mBio-, the online open-access journal of the American Society for Microbiology.
MedDay, a biotechnology company focused on the treatment of nervous system disorders, reports additional positive data from its pivotal Phase III clinical trial, MS-SPI, with MD1003, a highly-concentrated pharmaceutical grade biotin, in patients with Progressive Multiple Sclerosis.
Excessive activity of an immune system gene previously linked to schizophrenia reproduces neural and behavioral aspects of the disease in mice, according to a new study publishing on January 14 in the open-access journal PLOS Biology by Ashley Comer and Alberto Cruz-Martín of Boston University and colleagues.
A study published recently in the Journal of Neuroscience points, for the first time, to the gene trkC as a factor in susceptibility to the disease. The researchers define the specific mechanism for the formation of fear memories which will help in the development of new pharmacological and cognitive treatments.
Pioneering research using the tropical zebrafish could provide new insights into the genetic basis of myopathy, a type of human muscle disease.
› Verified 5 days ago
| Entity Name | Sdec |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1417531872 PECOS PAC ID: 2264830645 Enrollment ID: O20211015001207 |
News Archive
Low birth weight infants are host to numerous microorganisms immediately after birth, and the microbiomes of their mouths and gut start out very similar but differentiate significantly by day 15 according to a study published in mBio-, the online open-access journal of the American Society for Microbiology.
MedDay, a biotechnology company focused on the treatment of nervous system disorders, reports additional positive data from its pivotal Phase III clinical trial, MS-SPI, with MD1003, a highly-concentrated pharmaceutical grade biotin, in patients with Progressive Multiple Sclerosis.
Excessive activity of an immune system gene previously linked to schizophrenia reproduces neural and behavioral aspects of the disease in mice, according to a new study publishing on January 14 in the open-access journal PLOS Biology by Ashley Comer and Alberto Cruz-Martín of Boston University and colleagues.
A study published recently in the Journal of Neuroscience points, for the first time, to the gene trkC as a factor in susceptibility to the disease. The researchers define the specific mechanism for the formation of fear memories which will help in the development of new pharmacological and cognitive treatments.
Pioneering research using the tropical zebrafish could provide new insights into the genetic basis of myopathy, a type of human muscle disease.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Evan M Berger, 3235 Academy Ave Ste 200, Portsmouth, VA 23703-3200 Ph: (757) 397-7858 | Evan M Berger, 3235 Academy Ave Ste 200, Portsmouth, VA 23703-3200 Ph: (757) 397-7858 |
News Archive
Low birth weight infants are host to numerous microorganisms immediately after birth, and the microbiomes of their mouths and gut start out very similar but differentiate significantly by day 15 according to a study published in mBio-, the online open-access journal of the American Society for Microbiology.
MedDay, a biotechnology company focused on the treatment of nervous system disorders, reports additional positive data from its pivotal Phase III clinical trial, MS-SPI, with MD1003, a highly-concentrated pharmaceutical grade biotin, in patients with Progressive Multiple Sclerosis.
Excessive activity of an immune system gene previously linked to schizophrenia reproduces neural and behavioral aspects of the disease in mice, according to a new study publishing on January 14 in the open-access journal PLOS Biology by Ashley Comer and Alberto Cruz-Martín of Boston University and colleagues.
A study published recently in the Journal of Neuroscience points, for the first time, to the gene trkC as a factor in susceptibility to the disease. The researchers define the specific mechanism for the formation of fear memories which will help in the development of new pharmacological and cognitive treatments.
Pioneering research using the tropical zebrafish could provide new insights into the genetic basis of myopathy, a type of human muscle disease.
› Verified 5 days ago
Dr. Kimberly D Davis, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 620 John Paul Jones Circle, Naval Medical Center Portsmouth, Portsmouth, VA 23708 Phone: 757-953-5000 | |
Roger W Newsom, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 3235 Academy Ave, Suite 200, Portsmouth, VA 23703 Phone: 757-483-0400 | |
John T Edmonds, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 3235 Academy Ave, Suite 200, Portsmouth, VA 23703 Phone: 757-483-0400 | |
Mark A Pavilack, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 3235 Academy Ave, Suite 200, Portsmouth, VA 23703 Phone: 757-483-0400 | |
Dr. Kori A Elkins, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 3235 Academy Ave, Suite 200, Portsmouth, VA 23703 Phone: 757-483-0400 | |
Mark John Iacobucci, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 3235 Academy Ave, Suite 200, Portsmouth, VA 23703 Phone: 757-483-0400 Fax: 757-548-9563 |